A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety/tolerability, pharmacokinetics, and
efficacy of GFS101A in combination with Toripalimab in patients with advanced solid tumors.